CVE-2026-26323
RCE via crafted commit author in OpenClaw maintainer script
Is CVE-2026-26323 being exploited?
Not confirmed. CVE-2026-26323 does not appear in CISA's Known Exploited Vulnerabilities catalog, which records only exploitation that has been observed and reported publicly. That is evidence of absence of a report, not evidence the flaw is unattacked. EPSS currently estimates a 1.7% probability of exploitation in the next 30 days.
How severe is CVE-2026-26323?
CVE-2026-26323 is rated High with a CVSS score of 8.6. Severity describes how bad exploitation would be, not how likely it is: pair it with exploitation evidence before deciding what to patch first.
Is there a patch for CVE-2026-26323?
Yes. A fix has been recorded for CVE-2026-26323. The vendor advisory is the authority on the exact fixed version — apply it from there rather than from a summary.
What does CVE-2026-26323 affect?
CVE-2026-26323 affects OpenClaw (versions 2026.1.8–2026.2.13). Confirm the exact affected versions against the vendor advisory before deciding you are exposed.
What should I do about CVE-2026-26323?
Upgrade to 2026.2.14 patch
Exploitation status reflects CISA's KEV catalog as we last synced it. Check the catalog directly.
RCE via shell injection in update-clawcontributors.ts when repo contains malicious author email.
Patch when possible
- affected>= 2026.1.8 and < 2026.2.14
As published in the CVE Program record. A version outside these ranges is not a statement that it is unaffected — vendors sometimes understate a range, and distribution-backported builds carry upstream numbers that do not reflect what was patched into them.